Group One Trading
CPIX icon

Group One Trading’s Cumberland Pharmaceuticals CPIX Stock Holding History

Group One Trading’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$650 Sell
200
-10,600
-98% -$40.8K ﹤0.01% 7286
2025
Q4 		$43K Buy
10,800
+900
+9% +$2.67K ﹤0.01% 5727
2025
Q3 		$30.9K Buy
9,900
+9,400
+1,880% +$31.2K ﹤0.01% 6344
2025
Q2 		$1.68K Buy
500
+200
+67% +$947 ﹤0.01% 7455
2025
Q1 		$1.27K Buy
+300
New +$1.24K ﹤0.01% 7122
2024
Q4 		– Sell
-200
Closed -$256 – 7365
2024
Q3 		$256 Hold
200
– – ﹤0.01% 6441
2024
Q2 		$306 Hold
200
– – ﹤0.01% 6498
2024
Q1 		$336 Buy
+200
New +$399 ﹤0.01% 6776
2018
Q1 		– Sell
-400
Closed -$294K – 4887
2017
Q4 		$294K Buy
400
+300
+300% +$2.21K ﹤0.01% 2658
2017
Q3 		$1K Buy
+100
New +$692 ﹤0.01% 4695
2013
Q4 		– Sell
-1,000
Closed -$5K – 5252
2013
Q3 		$5K Sell
1,000
-600
-38% -$2.99K ﹤0.01% 4743
2013
Q2 		$8K Buy
+1,600
New +$7.96K ﹤0.01% 4514

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Group One Trading's CPIX Position: Q4 2025 in Review

Group One Trading sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 7,742 shares — an estimated $22.9K sold.

Group One Trading first reported a position in CPIX in Q2 2013 and held it in 4 quarters. The position peaked at $27.5K in Q2 2025. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Group One Trading reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 7,742 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $22.9K.
  • Group One Trading first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Group One Trading's Cumberland Pharmaceuticals position peaked at $27.5K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.